stella
beta
Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial — Stella
Recruiting
Back to Resectable Pancreatic Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(9 sites)
Taiwan
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
National Cheng Kung University Hospital, Tainan
Show all 9 locations
View full record on ClinicalTrials.gov